The vascular endothelial growth factor (VEGF) family, the regulator of blood and lymphatic
vessels, is mostly investigated in the tumor and ophthalmic field. However, the functions it …

The incidence of myocardial infarction (MI) increases every year worldwide. Better
diagnostic and prognostic biomarkers for clinical applications are the consistent pursuit of MI …

Ethnopharmacological relevance Cardiovascular diseases are still the leading cause of
death worldwide. Heart failure (HF), as the terminal stage of many cardiovascular diseases …

Simple Summary Bladder cancer is evidently a challenge as far as its prognosis and
treatment are concerned. The investigation of potential biomarkers and therapeutic targets is …

Background Coronary no-reflow phenomenon in ST-segment elevation myocardial
infarction (STEMI) is associated with a poor clinical prognosis. Although its pathophysiology …

Background: Myocardial infarction (MI) induces a repair response that ultimately generates a
stable fibrotic scar. Although the scar prevents cardiac rupture, an excessive profibrotic …

Aim Left ventricular remodeling (LVR) after myocardial infarction (MI) can lead to heart
failure, arrhythmia, and death. We aim to describe adverse LVR patterns at 6 months post-MI …

Introduction Collateral formation is insufficient in some patients with acute myocardial
infarction (AMI). Peripheral blood CD14++ CD16+ monocytes (intermediate monocytes; IM) …

Aim: To investigate the association between cardiovascular risk and biomarkers in patients
with Type 2 diabetes (T2DM). Methods: Cross-sectional study, with evaluation of traditional …

Aim The acute phase of myocardial infarction (MI) is accompanied by edema contributing to
tissue damage and disease outcome. Here, we aimed to identify the mechanism whereby …